| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
595 |
101 |
$190K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,659 |
1,299 |
$61K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,278 |
1,063 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
497 |
402 |
$4K |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
773 |
115 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
19 |
13 |
$256.55 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
46 |
37 |
$215.08 |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
569 |
89 |
$160.65 |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
255 |
193 |
$115.15 |
| 90791 |
Psychiatric diagnostic evaluation |
13 |
13 |
$102.78 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
327 |
263 |
$84.36 |
| 80053 |
Comprehensive metabolic panel |
208 |
165 |
$52.10 |
| 90832 |
Psychotherapy, 30 minutes with patient |
25 |
12 |
$47.94 |
| 84443 |
Thyroid stimulating hormone (TSH) |
77 |
59 |
$45.06 |
| 90834 |
Psychotherapy, 45 minutes with patient |
338 |
222 |
$23.03 |
| 81025 |
|
33 |
28 |
$0.00 |
| 80305 |
|
14 |
13 |
$0.00 |
| 82077 |
|
26 |
24 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
42 |
25 |
$0.00 |
| 80320 |
|
19 |
16 |
$0.00 |